The concentration of PAD4 was significantly higher in SF from patients with RA than OA (mean ± SD 101.2 ± 189.2 and 7.3 ± 18.6 ng/mL, respectively; P = 0.0077) (Fig. 4a). Here, PADI4 is linked to rheumatoid arthritis.